BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen D, Jin D, Huang S, Wu J, Xu M, Liu T, Dong W, Liu X, Wang S, Zhong W, Liu Y, Jiang R, Piao M, Wang B, Cao H. Clostridium butyricum, a butyrate-producing probiotic, inhibits intestinal tumor development through modulating Wnt signaling and gut microbiota. Cancer Lett 2020;469:456-67. [PMID: 31734354 DOI: 10.1016/j.canlet.2019.11.019] [Cited by in Crossref: 60] [Cited by in F6Publishing: 57] [Article Influence: 20.0] [Reference Citation Analysis]
Number Citing Articles
1 Mohseni AH, Taghinezhad-s S, Fu X. Gut microbiota-derived metabolites and colorectal cancer: New insights and updates. Microbial Pathogenesis 2020;149:104569. [DOI: 10.1016/j.micpath.2020.104569] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Wen S, He L, Zhong Z, Zhao R, Weng S, Mi H, Liu F. Stigmasterol Restores the Balance of Treg/Th17 Cells by Activating the Butyrate-PPARγ Axis in Colitis. Front Immunol 2021;12:741934. [PMID: 34691046 DOI: 10.3389/fimmu.2021.741934] [Reference Citation Analysis]
3 Taghinezhad-S S, Mohseni AH, Fu X. Intervention on gut microbiota may change the strategy for management of colorectal cancer. J Gastroenterol Hepatol 2021;36:1508-17. [PMID: 33295040 DOI: 10.1111/jgh.15369] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Luo GF, Chen WH, Zeng X, Zhang XZ. Cell primitive-based biomimetic functional materials for enhanced cancer therapy. Chem Soc Rev 2021;50:945-85. [PMID: 33226037 DOI: 10.1039/d0cs00152j] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 5.5] [Reference Citation Analysis]
5 Cheng Y, Liu J, Ling Z. Short-chain fatty acids-producing probiotics: A novel source of psychobiotics. Crit Rev Food Sci Nutr 2021;:1-31. [PMID: 33955288 DOI: 10.1080/10408398.2021.1920884] [Reference Citation Analysis]
6 Jiang H, Zeng W, Zhang X, Pei Y, Zhang H, Li Y. The role of gut microbiota in patients with benign and malignant brain tumors: a pilot study. Bioengineered 2022;13:7847-59. [PMID: 35291914 DOI: 10.1080/21655979.2022.2049959] [Reference Citation Analysis]
7 Pu Z, Yang F, Wang L, Diao Y, Chen D. Advancements of compounds targeting Wnt and Notch signalling pathways in the treatment of inflammatory bowel disease and colon cancer. J Drug Target 2021;29:507-19. [PMID: 33307848 DOI: 10.1080/1061186X.2020.1864741] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Mansour B, Monyók Á, Makra N, Gajdács M, Vadnay I, Ligeti B, Juhász J, Szabó D, Ostorházi E. Bladder cancer-related microbiota: examining differences in urine and tissue samples. Sci Rep 2020;10:11042. [PMID: 32632181 DOI: 10.1038/s41598-020-67443-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
9 Di DS, Li C, Dai Y, Wei MH, Wang SS, Song WJ, Zhou HL, Cui Y, Zhang RY, Huang Q, Wang Q. Integrative Analysis of LGR5/6 Gene Variants, Gut Microbiota Composition and Osteoporosis Risk in Elderly Population. Front Microbiol 2021;12:765008. [PMID: 34795657 DOI: 10.3389/fmicb.2021.765008] [Reference Citation Analysis]
10 Xu JY, Liu MT, Tao T, Zhu X, Fei FQ. The role of gut microbiota in tumorigenesis and treatment. Biomed Pharmacother 2021;138:111444. [PMID: 33662679 DOI: 10.1016/j.biopha.2021.111444] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Dai X, Guo Z, Chen D, Li L, Song X, Liu T, Jin G, Li Y, Liu Y, Ajiguli A, Yang C, Wang B, Cao H. Maternal sucralose intake alters gut microbiota of offspring and exacerbates hepatic steatosis in adulthood. Gut Microbes 2020;11:1043-63. [PMID: 32228300 DOI: 10.1080/19490976.2020.1738187] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
12 Simonsen D, Cady N, Zhang C, Shrode RL, McCormick ML, Spitz DR, Chimenti MS, Wang K, Mangalam A, Lehmler HJ. The Effects of Benoxacor on the Liver and Gut Microbiome of C57BL/6 Mice. Toxicol Sci 2021:kfab142. [PMID: 34850242 DOI: 10.1093/toxsci/kfab142] [Reference Citation Analysis]
13 Mirzaei R, Afaghi A, Babakhani S, Sohrabi MR, Hosseini-Fard SR, Babolhavaeji K, Khani Ali Akbari S, Yousefimashouf R, Karampoor S. Role of microbiota-derived short-chain fatty acids in cancer development and prevention. Biomed Pharmacother 2021;139:111619. [PMID: 33906079 DOI: 10.1016/j.biopha.2021.111619] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Youssef M, Ahmed HY, Zongo A, Korin A, Zhan F, Hady E, Umair M, Shahid Riaz Rajoka M, Xiong Y, Li B. Probiotic Supplements: Their Strategies in the Therapeutic and Prophylactic of Human Life-Threatening Diseases. Int J Mol Sci 2021;22:11290. [PMID: 34681948 DOI: 10.3390/ijms222011290] [Reference Citation Analysis]
15 Zhang W, An Y, Qin X, Wu X, Wang X, Hou H, Song X, Liu T, Wang B, Huang X, Cao H. Gut Microbiota-Derived Metabolites in Colorectal Cancer: The Bad and the Challenges. Front Oncol 2021;11:739648. [PMID: 34733783 DOI: 10.3389/fonc.2021.739648] [Reference Citation Analysis]
16 Rad AH, Aghebati-Maleki L, Kafil HS, Abbasi A. Molecular mechanisms of postbiotics in colorectal cancer prevention and treatment. Crit Rev Food Sci Nutr 2021;61:1787-803. [PMID: 32410512 DOI: 10.1080/10408398.2020.1765310] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
17 Lamichhane P, Maiolini M, Alnafoosi O, Hussein S, Alnafoosi H, Umbela S, Richardson T, Alla N, Lamichhane N, Subhadra B, Deshmukh RR. Colorectal Cancer and Probiotics: Are Bugs Really Drugs? Cancers (Basel) 2020;12:E1162. [PMID: 32380712 DOI: 10.3390/cancers12051162] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
18 Armstrong H, Bording-Jorgensen M, Wine E. The Multifaceted Roles of Diet, Microbes, and Metabolites in Cancer. Cancers (Basel) 2021;13:767. [PMID: 33673140 DOI: 10.3390/cancers13040767] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Thomson P, Núñez P, Quera R, Bay C. Gastrointestinal microbiome, what is behind faecal microbiota transplantation? New Microbes New Infect 2021;42:100898. [PMID: 34168881 DOI: 10.1016/j.nmni.2021.100898] [Reference Citation Analysis]
20 Zou R, Wang Y, Ye F, Zhang X, Wang M, Cui S. Mechanisms of primary and acquired resistance to PD-1/PD-L1 blockade and the emerging role of gut microbiome. Clin Transl Oncol 2021. [PMID: 34002348 DOI: 10.1007/s12094-021-02637-2] [Reference Citation Analysis]
21 Wang Y, Du J, Wu X, Abdelrehem A, Ren Y, Liu C, Zhou X, Wang S. Crosstalk between autophagy and microbiota in cancer progression. Mol Cancer 2021;20:163. [PMID: 34895252 DOI: 10.1186/s12943-021-01461-0] [Reference Citation Analysis]
22 Gao ZY, Cui Z, Yan YQ, Ning LJ, Wang ZH, Hong J. Microbe-based management for colorectal cancer. Chin Med J (Engl) 2021;134:2922-30. [PMID: 34855639 DOI: 10.1097/CM9.0000000000001887] [Reference Citation Analysis]
23 dos Santos Cruz BC, da Silva Duarte V, Giacomini A, Corich V, de Paula SO, da Silva Fialho L, Guimarães VM, de Luces Fortes Ferreira CL, Gouveia Peluzio MDC. Synbiotic VSL#3 and yacon-based product modulate the intestinal microbiota and prevent the development of pre-neoplastic lesions in a colorectal carcinogenesis model. Appl Microbiol Biotechnol 2020;104:8837-57. [DOI: 10.1007/s00253-020-10863-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
24 Zhu R, Lang T, Yan W, Zhu X, Huang X, Yin Q, Li Y. Gut Microbiota: Influence on Carcinogenesis and Modulation Strategies by Drug Delivery Systems to Improve Cancer Therapy. Adv Sci (Weinh) 2021;8:2003542. [PMID: 34026439 DOI: 10.1002/advs.202003542] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Robinson JM, Cando-Dumancela C, Antwis RE, Cameron R, Liddicoat C, Poudel R, Weinstein P, Breed MF. Exposure to airborne bacteria depends upon vertical stratification and vegetation complexity. Sci Rep 2021;11:9516. [PMID: 33947905 DOI: 10.1038/s41598-021-89065-y] [Reference Citation Analysis]
26 Le F, Yang L, Han Y, Zhong Y, Zhan F, Feng Y, Hu H, Chen T, Tan B. TPL Inhibits the Invasion and Migration of Drug-Resistant Ovarian Cancer by Targeting the PI3K/AKT/NF-κB-Signaling Pathway to Inhibit the Polarization of M2 TAMs. Front Oncol 2021;11:704001. [PMID: 34381726 DOI: 10.3389/fonc.2021.704001] [Reference Citation Analysis]
27 Yi Z, Sadiq FA, Wang H, Zhao J, Zhang H, Lu W, Chen W. Establishment and evaluation of a method for efficient screening of Clostridium butyricum. Folia Microbiol (Praha) 2020;65:917-24. [PMID: 32621129 DOI: 10.1007/s12223-020-00803-7] [Reference Citation Analysis]
28 Qin X, Gu Y, Liu T, Wang C, Zhong W, Wang B, Cao H. Gut mycobiome: A promising target for colorectal cancer. Biochim Biophys Acta Rev Cancer 2021;1875:188489. [PMID: 33278512 DOI: 10.1016/j.bbcan.2020.188489] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
29 Chen L, Zhai Y, Wang Y, Fearon ER, Núñez G, Inohara N, Cho KR. Altering the Microbiome Inhibits Tumorigenesis in a Mouse Model of Oviductal High-Grade Serous Carcinoma. Cancer Res 2021;81:3309-18. [PMID: 33863776 DOI: 10.1158/0008-5472.CAN-21-0106] [Reference Citation Analysis]
30 Liu M, Xie W, Wan X, Deng T. Clostridium butyricum modulates gut microbiota and reduces colitis associated colon cancer in mice. Int Immunopharmacol 2020;88:106862. [PMID: 32771947 DOI: 10.1016/j.intimp.2020.106862] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
31 Liang J, Kou S, Chen C, Raza SHA, Wang S, Ma X, Zhang WJ, Nie C. Effects of Clostridium butyricum on growth performance, metabonomics and intestinal microbial differences of weaned piglets. BMC Microbiol 2021;21:85. [PMID: 33752593 DOI: 10.1186/s12866-021-02143-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Pan S, Guo Y, Hong F, Xu P, Zhai Y. Therapeutic potential of melatonin in colorectal cancer: Focus on lipid metabolism and gut microbiota. Biochim Biophys Acta Mol Basis Dis 2022;1868:166281. [PMID: 34610472 DOI: 10.1016/j.bbadis.2021.166281] [Reference Citation Analysis]
33 Ionica E, Gaina G, Tica M, Chifiriuc M, Gradisteanu-pircalabioru G. Contribution of Epithelial and Gut Microbiome Inflammatory Biomarkers to the Improvement of Colorectal Cancer Patients’ Stratification. Front Oncol 2022;11:811486. [DOI: 10.3389/fonc.2021.811486] [Reference Citation Analysis]
34 Peng Y, Nie Y, Yu J, Wong CC. Microbial Metabolites in Colorectal Cancer: Basic and Clinical Implications. Metabolites 2021;11:159. [PMID: 33802045 DOI: 10.3390/metabo11030159] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Lu X, Qiao S, Peng C, Yan W, Xu Z, Qu J, Hou Y, Zhao S, Chen P, Wang T. Bornlisy Attenuates Colitis-Associated Colorectal Cancer via Inhibiting GPR43-Mediated Glycolysis. Front Nutr 2021;8:706382. [PMID: 34869511 DOI: 10.3389/fnut.2021.706382] [Reference Citation Analysis]
36 Luo Y, Zhou T. Connecting the dots: Targeting the microbiome in drug toxicity. Med Res Rev 2021. [PMID: 33856076 DOI: 10.1002/med.21805] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Fan J, Niu M, Qin Y, Sun Y, Zhang X. Progress of Engineered Bacteria for Tumor Therapy. Advanced Drug Delivery Reviews 2022. [DOI: 10.1016/j.addr.2022.114296] [Reference Citation Analysis]
38 Cosín-Roger J, Ortiz-Masia D, Barrachina MD, Calatayud S. Metabolite Sensing GPCRs: Promising Therapeutic Targets for Cancer Treatment? Cells 2020;9:E2345. [PMID: 33113952 DOI: 10.3390/cells9112345] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Zhufeng Y, Xu J, Miao M, Wang Y, Li Y, Huang B, Guo Y, Tian J, Sun X, Li J, Lu D, Li Z, Li Y, He J. Modification of Intestinal Microbiota Dysbiosis by Low-Dose Interleukin-2 in Dermatomyositis: A Post Hoc Analysis From a Clinical Trial Study. Front Cell Infect Microbiol 2022;12:757099. [DOI: 10.3389/fcimb.2022.757099] [Reference Citation Analysis]
40 Garavaglia B, Vallino L, Ferraresi A, Esposito A, Salwa A, Vidoni C, Gentilli S, Isidoro C. Butyrate Inhibits Colorectal Cancer Cell Proliferation through Autophagy Degradation of β-Catenin Regardless of APC and β-Catenin Mutational Status. Biomedicines 2022;10:1131. [DOI: 10.3390/biomedicines10051131] [Reference Citation Analysis]
41 Tanaka Y, Shimizu S, Shirotani M, Yorozu K, Kitamura K, Oehorumu M, Kawai Y, Fukuzawa Y. Nutrition and Cancer Risk from the Viewpoint of the Intestinal Microbiome. Nutrients 2021;13:3326. [PMID: 34684330 DOI: 10.3390/nu13103326] [Reference Citation Analysis]
42 Abbasi A, Rad AH, Ghasempour Z, Sabahi S, Kafil HS, Hasannezhad P, Rahbar Saadat Y, Shahbazi N. The biological activities of postbiotics in gastrointestinal disorders. Crit Rev Food Sci Nutr 2021;:1-22. [PMID: 33715539 DOI: 10.1080/10408398.2021.1895061] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
43 Ngowi EE, Wang YZ, Khattak S, Khan NH, Mahmoud SSM, Helmy YASH, Jiang QY, Li T, Duan SF, Ji XY, Wu DD. Impact of the factors shaping gut microbiota on obesity. J Appl Microbiol 2021. [PMID: 33570819 DOI: 10.1111/jam.15036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Homayouni Rad A, Aghebati Maleki L, Samadi Kafil H, Fathi Zavoshti H, Abbasi A. Postbiotics as Promising Tools for Cancer Adjuvant Therapy. Adv Pharm Bull 2021;11:1-5. [PMID: 33747846 DOI: 10.34172/apb.2021.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
45 Geng HW, Yin FY, Zhang ZF, Gong X, Yang Y. Butyrate Suppresses Glucose Metabolism of Colorectal Cancer Cells via GPR109a-AKT Signaling Pathway and Enhances Chemotherapy. Front Mol Biosci 2021;8:634874. [PMID: 33855046 DOI: 10.3389/fmolb.2021.634874] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
46 Guan B, Tong J, Hao H, Yang Z, Chen K, Xu H, Wang A. Bile acid coordinates microbiota homeostasis and systemic immunometabolism in cardiometabolic diseases. Acta Pharmaceutica Sinica B 2021. [DOI: 10.1016/j.apsb.2021.12.011] [Reference Citation Analysis]
47 Zhou Y, Xu J, Luo H, Meng X, Chen M, Zhu D. Wnt signaling pathway in cancer immunotherapy. Cancer Lett 2022;525:84-96. [PMID: 34740608 DOI: 10.1016/j.canlet.2021.10.034] [Reference Citation Analysis]
48 Hu M, Huang L. Strategies targeting tumor immune and stromal microenvironment and their clinical relevance. Adv Drug Deliv Rev 2022;:114137. [PMID: 35143893 DOI: 10.1016/j.addr.2022.114137] [Reference Citation Analysis]
49 Chang SC, Shen MH, Liu CY, Pu CM, Hu JM, Huang CJ. A gut butyrate-producing bacterium Butyricicoccus pullicaecorum regulates short-chain fatty acid transporter and receptor to reduce the progression of 1,2-dimethylhydrazine-associated colorectal cancer. Oncol Lett 2020;20:327. [PMID: 33101496 DOI: 10.3892/ol.2020.12190] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
50 Cheng L, Qi C, Yang H, Lu M, Cai Y, Fu T, Ren J, Jin Q, Zhang X. gutMGene: a comprehensive database for target genes of gut microbes and microbial metabolites. Nucleic Acids Res 2021:gkab786. [PMID: 34500458 DOI: 10.1093/nar/gkab786] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
51 Caspi M, Wittenstein A, Kazelnik M, Shor-Nareznoy Y, Rosin-Arbesfeld R. Therapeutic targeting of the oncogenic Wnt signaling pathway for treating colorectal cancer and other colonic disorders. Adv Drug Deliv Rev 2021;169:118-36. [PMID: 33346022 DOI: 10.1016/j.addr.2020.12.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
52 Badran M, Mashaqi S, Gozal D. The gut microbiome as a target for adjuvant therapy in obstructive sleep apnea. Expert Opin Ther Targets 2020;24:1263-82. [PMID: 33180654 DOI: 10.1080/14728222.2020.1841749] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
53 He C, Wu H, Lv Y, You H, Zha L, Li Q, Huang Y, Tian J, Chen Q, Shen Y, Xiong S, Xue F. Gastrointestinal Development and Microbiota Responses of Geese to Honeycomb Flavonoids Supplementation. Front Vet Sci 2021;8:739237. [PMID: 34733903 DOI: 10.3389/fvets.2021.739237] [Reference Citation Analysis]
54 Hsiao YP, Chen HL, Tsai JN, Lin MY, Liao JW, Wei MS, Ko JL, Ou CC. Administration of Lactobacillus reuteri Combined with Clostridium butyricum Attenuates Cisplatin-Induced Renal Damage by Gut Microbiota Reconstitution, Increasing Butyric Acid Production, and Suppressing Renal Inflammation. Nutrients 2021;13:2792. [PMID: 34444952 DOI: 10.3390/nu13082792] [Reference Citation Analysis]
55 Zhang Z, Wan H, Han J, Sun X, Yu R, Liu B, Lu C, Zhou J, Su X. Ameliorative effect of tuna elastin peptides on AIA mice by regulating the composition of intestinal microorganisms and SCFAs. Journal of Functional Foods 2022;92:105076. [DOI: 10.1016/j.jff.2022.105076] [Reference Citation Analysis]
56 Sanchez-Rodriguez E, Egea-Zorrilla A, Plaza-Díaz J, Aragón-Vela J, Muñoz-Quezada S, Tercedor-Sánchez L, Abadia-Molina F. The Gut Microbiota and Its Implication in the Development of Atherosclerosis and Related Cardiovascular Diseases. Nutrients 2020;12:E605. [PMID: 32110880 DOI: 10.3390/nu12030605] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 16.5] [Reference Citation Analysis]
57 Mori G, Pasca MR. Gut Microbial Signatures in Sporadic and Hereditary Colorectal Cancer. Int J Mol Sci 2021;22:1312. [PMID: 33525662 DOI: 10.3390/ijms22031312] [Reference Citation Analysis]
58 Stoeva MK, Garcia-So J, Justice N, Myers J, Tyagi S, Nemchek M, McMurdie PJ, Kolterman O, Eid J. Butyrate-producing human gut symbiont, Clostridium butyricum, and its role in health and disease. Gut Microbes 2021;13:1-28. [PMID: 33874858 DOI: 10.1080/19490976.2021.1907272] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
59 Torres-Maravilla E, Boucard AS, Mohseni AH, Taghinezhad-S S, Cortes-Perez NG, Bermúdez-Humarán LG. Role of Gut Microbiota and Probiotics in Colorectal Cancer: Onset and Progression. Microorganisms 2021;9:1021. [PMID: 34068653 DOI: 10.3390/microorganisms9051021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
60 Choi SI, Son JH, Kim N, Kim YS, Nam RH, Park JH, Song CH, Yu JE, Lee DH, Yoon K, Min H, Kim YR, Seok YJ. Changes in Cecal Microbiota and Short-chain Fatty Acid During Lifespan of the Rat. J Neurogastroenterol Motil 2021;27:134-46. [PMID: 33380558 DOI: 10.5056/jnm20148] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
61 Xu S, Yin W, Zhang Y, Lv Q, Yang Y, He J. Foes or Friends? Bacteria Enriched in the Tumor Microenvironment of Colorectal Cancer. Cancers (Basel) 2020;12:E372. [PMID: 32041122 DOI: 10.3390/cancers12020372] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
62 Wang W, Cai H, Zhang A, Chen Z, Chang W, Liu G, Deng X, Bryden WL, Zheng A. Enterococcus faecium Modulates the Gut Microbiota of Broilers and Enhances Phosphorus Absorption and Utilization. Animals (Basel) 2020;10:E1232. [PMID: 32698425 DOI: 10.3390/ani10071232] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
63 Janney A, Powrie F, Mann EH. Host–microbiota maladaptation in colorectal cancer. Nature 2020;585:509-17. [DOI: 10.1038/s41586-020-2729-3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 17.0] [Reference Citation Analysis]
64 Abbasi A, Hajipour N, Hasannezhad P, Baghbanzadeh A, Aghebati-maleki L. Potential in vivo delivery routes of postbiotics. Critical Reviews in Food Science and Nutrition. [DOI: 10.1080/10408398.2020.1865260] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
65 Hou H, Chen D, Zhang K, Zhang W, Liu T, Wang S, Dai X, Wang B, Zhong W, Cao H. Gut microbiota-derived short-chain fatty acids and colorectal cancer: Ready for clinical translation? Cancer Lett 2022;526:225-35. [PMID: 34843863 DOI: 10.1016/j.canlet.2021.11.027] [Reference Citation Analysis]
66 Song X, An Y, Chen D, Zhang W, Wu X, Li C, Wang S, Dong W, Wang B, Liu T, Zhong W, Sun T, Cao H. Microbial metabolite deoxycholic acid promotes vasculogenic mimicry formation in intestinal carcinogenesis. Cancer Sci 2021. [PMID: 34811848 DOI: 10.1111/cas.15208] [Reference Citation Analysis]
67 Yang J, Li Y, Wen Z, Liu W, Meng L, Huang H. Oscillospira - a candidate for the next-generation probiotics. Gut Microbes 2021;13:1987783. [PMID: 34693878 DOI: 10.1080/19490976.2021.1987783] [Reference Citation Analysis]
68 Mancin L, Rollo I, Mota JF, Piccini F, Carletti M, Susto GA, Valle G, Paoli A. Optimizing Microbiota Profiles for Athletes. Exerc Sport Sci Rev. 2021;49:42-49. [PMID: 33044333 DOI: 10.1249/jes.0000000000000236] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
69 Li J, Zhang AH, Wu FF, Wang XJ. Alterations in the Gut Microbiota and Their Metabolites in Colorectal Cancer: Recent Progress and Future Prospects. Front Oncol 2022;12:841552. [PMID: 35223525 DOI: 10.3389/fonc.2022.841552] [Reference Citation Analysis]
70 Mahmoud YA, El-Naggar ME, Abdel-Megeed A, El-Newehy M. Recent Advancements in Microbial Polysaccharides: Synthesis and Applications. Polymers (Basel) 2021;13:4136. [PMID: 34883639 DOI: 10.3390/polym13234136] [Reference Citation Analysis]
71 Qi C, Wang P, Fu T, Lu M, Cai Y, Chen X, Cheng L. A comprehensive review for gut microbes: technologies, interventions, metabolites and diseases. Brief Funct Genomics 2021;20:42-60. [PMID: 33554248 DOI: 10.1093/bfgp/elaa029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
72 Yenuganti VR, Yadala R, Azad R, Singh S, Chiluka V, Ahire J, Reddanna P. In vitro evaluation of anticancer effects of different probiotic strains on HCT-116 cell line. J Appl Microbiol 2021. [PMID: 33694215 DOI: 10.1111/jam.15060] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
73 Meng X, Wu S, Hu W, Zhu Z, Yang G, Zhang Y, Qin C, Yang L, Nie G. Clostridium butyricum improves immune responses and remodels the intestinal microbiota of common carp (Cyprinus carpio L.). Aquaculture 2021;530:735753. [DOI: 10.1016/j.aquaculture.2020.735753] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
74 Xiao Z, Liu L, Pei X, Sun W, Jin Y, Yang ST, Wang M. A Potential Probiotic for Diarrhea: Clostridium tyrobutyricum Protects Against LPS-Induced Epithelial Dysfunction via IL-22 Produced By Th17 Cells in the Ileum. Front Immunol 2021;12:758227. [PMID: 34917080 DOI: 10.3389/fimmu.2021.758227] [Reference Citation Analysis]
75 Ranjbar M, Salehi R, Haghjooy Javanmard S, Rafiee L, Faraji H, Jafarpor S, Ferns GA, Ghayour-Mobarhan M, Manian M, Nedaeinia R. The dysbiosis signature of Fusobacterium nucleatum in colorectal cancer-cause or consequences? A systematic review. Cancer Cell Int 2021;21:194. [PMID: 33823861 DOI: 10.1186/s12935-021-01886-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
76 Hajjar R, Richard CS, Santos MM. The role of butyrate in surgical and oncological outcomes in colorectal cancer. Am J Physiol Gastrointest Liver Physiol 2021;320:G601-8. [PMID: 33404375 DOI: 10.1152/ajpgi.00316.2020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
77 Grüner N, Mattner J. Bile Acids and Microbiota: Multifaceted and Versatile Regulators of the Liver-Gut Axis. Int J Mol Sci 2021;22:1397. [PMID: 33573273 DOI: 10.3390/ijms22031397] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
78 Dai X, Hou H, Zhang W, Liu T, Li Y, Wang S, Wang B, Cao H. Microbial Metabolites: Critical Regulators in NAFLD.Front Microbiol. 2020;11:567654. [PMID: 33117316 DOI: 10.3389/fmicb.2020.567654] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
79 Carretta MD, Quiroga J, López R, Hidalgo MA, Burgos RA. Participation of Short-Chain Fatty Acids and Their Receptors in Gut Inflammation and Colon Cancer. Front Physiol 2021;12:662739. [PMID: 33897470 DOI: 10.3389/fphys.2021.662739] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
80 Panebianco C, Latiano T, Pazienza V. Microbiota Manipulation by Probiotics Administration as Emerging Tool in Cancer Prevention and Therapy. Front Oncol 2020;10:679. [PMID: 32523887 DOI: 10.3389/fonc.2020.00679] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
81 van Olst L, Roks SJM, Kamermans A, Verhaar BJH, van der Geest AM, Muller M, van der Flier WM, de Vries HE. Contribution of Gut Microbiota to Immunological Changes in Alzheimer's Disease. Front Immunol 2021;12:683068. [PMID: 34135909 DOI: 10.3389/fimmu.2021.683068] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
82 Johnson WT, Dorn NC, Ogbonna DA, Bottini N, Shah NJ. Lipid‐based regulators of immunity. Bioengineering & Transla Med. [DOI: 10.1002/btm2.10288] [Reference Citation Analysis]
83 Wu J, Zhao Y, Wang X, Kong L, Johnston LJ, Lu L, Ma X. Dietary nutrients shape gut microbes and intestinal mucosa via epigenetic modifications. Critical Reviews in Food Science and Nutrition. [DOI: 10.1080/10408398.2020.1828813] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
84 Chen YS, Li J, Menon R, Jayaraman A, Lee K, Huang Y, Dashwood WM, Zhang K, Sun D, Dashwood RH. Dietary spinach reshapes the gut microbiome in an Apc-mutant genetic background: mechanistic insights from integrated multi-omics. Gut Microbes 2021;13:1972756. [PMID: 34494932 DOI: 10.1080/19490976.2021.1972756] [Reference Citation Analysis]
85 Salvi PS, Cowles RA. Butyrate and the Intestinal Epithelium: Modulation of Proliferation and Inflammation in Homeostasis and Disease. Cells 2021;10:1775. [PMID: 34359944 DOI: 10.3390/cells10071775] [Cited by in F6Publishing: 1] [Reference Citation Analysis]